Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Molecular Pharmacology
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Molecular Pharmacology

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit molpharm on Facebook
  • Follow molpharm on Twitter
  • Follow molpharm on LinkedIn
Research ArticleArticle

Activity of adenylyl cyclase type 6 is suppressed by direct binding of the cytoskeletal protein 4.1G

Masaki Saito, Linran Cui, Marina Hirano, Guanjie Li, Teruyuki Yanagisawa, Takeya Sato and Jun Sukegawa
Molecular Pharmacology August 5, 2019, mol.119.116426; DOI: https://doi.org/10.1124/mol.119.116426
Masaki Saito
1 Tohoku University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Masaki Saito
Linran Cui
1 Tohoku University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Marina Hirano
2 Shokei Gakuin University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Guanjie Li
1 Tohoku University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Teruyuki Yanagisawa
3 Tohoku Fukushi University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Takeya Sato
1 Tohoku University School of Medicine;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jun Sukegawa
2 Shokei Gakuin University;
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF
Loading

Article Information

mol.119.116426
DOI 
https://doi.org/10.1124/mol.119.116426
PubMed 
31383768

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0026-895X
Online ISSN 
1521-0111
History 
  • Published online August 5, 2019.

Article Versions

  • You are currently viewing an Earlier version of this article (August 5, 2019 - 10:43).
  • View the most recent version of this article
Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Masaki Saito1,*,
  2. Linran Cui1,
  3. Marina Hirano2,
  4. Guanjie Li1,
  5. Teruyuki Yanagisawa3,
  6. Takeya Sato1, and
  7. Jun Sukegawa2
  1. 1 Tohoku University School of Medicine;
  2. 2 Shokei Gakuin University;
  3. 3 Tohoku Fukushi University
  1. ↵*Address correspondence to: saimasa{at}med.tohoku.ac.jp

Statistics from Altmetric.com

Article usage

Article usage: August 2019 to January 2023

AbstractFullPdf
Aug 2019328071
Sep 20193613836
Oct 20191042117
Nov 20191111510
Dec 201998117
Jan 20208166
Feb 202010353
Mar 20209534
Apr 20209953
May 202013674
Jun 202011242
Jul 202011555
Aug 202010330
Sep 20202310437
Oct 2020211610
Nov 202089813
Dec 2020248116
Jan 20211413324
Feb 2021111525
Mar 2021103012
Apr 2021121613
May 2021141820
Jun 20215113
Jul 202121112
Aug 202182211
Sep 202132013
Oct 202121222
Nov 202111732
Dec 20215148
Jan 202242628
Feb 20224155
Mar 202232417
Apr 202231715
May 202222414
Jun 202222125
Jul 202231813
Aug 20226155
Sep 202242119
Oct 202221114
Nov 2022293
Dec 20222135
Jan 2023186

Next
Back to top

In this issue

Molecular Pharmacology: 103 (2)
Molecular Pharmacology
Vol. 103, Issue 2
1 Feb 2023
  • Table of Contents
  • About the Cover
  • Index by author
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Molecular Pharmacology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Activity of adenylyl cyclase type 6 is suppressed by direct binding of the cytoskeletal protein 4.1G
(Your Name) has forwarded a page to you from Molecular Pharmacology
(Your Name) thought you would be interested in this article in Molecular Pharmacology.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Research ArticleArticle

Activity of adenylyl cyclase type 6 is suppressed by direct binding of the cytoskeletal protein 4.1G

Masaki Saito, Linran Cui, Marina Hirano, Guanjie Li, Teruyuki Yanagisawa, Takeya Sato and Jun Sukegawa
Molecular Pharmacology August 5, 2019, mol.119.116426; DOI: https://doi.org/10.1124/mol.119.116426

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Research ArticleArticle

Activity of adenylyl cyclase type 6 is suppressed by direct binding of the cytoskeletal protein 4.1G

Masaki Saito, Linran Cui, Marina Hirano, Guanjie Li, Teruyuki Yanagisawa, Takeya Sato and Jun Sukegawa
Molecular Pharmacology August 5, 2019, mol.119.116426; DOI: https://doi.org/10.1124/mol.119.116426
del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF + SI
  • PDF

Related Articles

Cited By...

More in this TOC Section

  • Fatty acid amide hydrolase in cisplatin nephrotoxicity
  • eCB Signaling System in hiPSC-Derived Neuronal Cultures
  • Benzbromarone relaxes airway smooth muscle via BK activation
Show more Article

Similar Articles

Advertisement
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About Molecular Pharmacology
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Journal of Pharmacology and Experimental Therapeutics
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0111 (Online)

Copyright © 2023 by the American Society for Pharmacology and Experimental Therapeutics